Book your standgotocphi.com/jp19Big Sight Exhibition Center Tokyo, Japan

18-20 March 2019

of CPhI Japan visitors found new partners for future collaboration*

* 2018 post show survey

20,000+pharma professionals

From 60+ Countries

5 eventsin 1 location

3 daysof business, learning &

networking opportunities

“Attending CPhI Japan was a good chance to get in contact with Japanese companies and to understand the Japanese pharma industry and trends. We are looking forward to attending this wonderful exhibition again and to exchange our experience with local Japanese companies.”Andrea SalvadoriSales Area Manager PQE

gotocphi.com/jp19 For more information contact: salesoperations@ubm.com

“As an integrated pharma company, CPhI Japan is an important and effective platform for us to meet existing and new partners, but also to

raise our profile and brand awareness.”Silke Oeschger

Marketing and Communication Manager Dr. Reddy’s Laboratories

87%

Facts & figuresof the 2018 show550 exhibitors from 32 countriesand 19,509 visitors from 67 countries!

Visitor business categories

12.4% Trading Company

33% Pharmaceutical manufacturing/Pharmaceutical contract manufacturing

22.6%

32% Others

Positions - Pharmaceutical manufacturing/ Pharmaceutical contract manufacturing

Top 10 visitor countries

Fine Chemical/ API/ Intermediates Manufacturing

Positions - Fine chemical manufacturing/ Intermediate manufacturing/ API manufacturing

36.5%

12%

10.2%

10.7%

4.9%

25.7%

Research/Development

Quality Control/Production

Purchasing/Procurement/Logistic

Management

Marketing

Other

Primary purpose of visitLooking for new suppliers, ingredients & services 44%

Attending conferences and exhibitor presentations10%

Maintaining business relationships10%

Others4%

31.2%

8.6%

8.3%

6.8%

6.1%

39%

Obtaining market / product information32%

1. Japan 3. South Korea2. China 4. India

5. Taiwan 6. Germany 7. Spain

10. Italy

Research/Development

Quality Control/Production

Purchasing/Procurement/Logistic

Management

Marketing

Other

8. USA

9. Vietnam

For more on market trends visit www.cphi.com/japan

Entering the next stage as a global hub for drug developmentJapan has joined the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme (PIC/S). This enables overseas suppliers to synchronise with Japanese pharmaceutical manufacturers regarding manufacturing and quality control. In addition, Japan’s pharmaceutical industry will become more international as well as easier for foreign suppliers to enter the Japanese market!

1. Japan is the 3rd largest pharma market in the world

2. The Japanese pharma market is expected to reach a value of $105bn by 2021 and $109bn by 2026

3. The global biopharmaceutical market is forecasted to reach $306bn by 2020. Asia-Pacific is forecasted to emerge as the fastest growing market with a CAGR of 12.2%

Japan has a high dependency rate for APIson overseas suppliers of generic drugs

Imported

of APIs are imported from outside Japan for Generic Drug

Manufacturing in Japan

51.2% - 57.8%

Top 6 API suppliers in two categories*

*Value based

1. Korea 31% 2. China 12.3% 3. Spain 9.9% 4. Italy 8.9% 5. Hungary 8.4% 6. India 7.2%

1. India 30% 2. Korea 26% 3. China 24.1% 4. Germany 9.6% 5. Italy 1.4% 6. Taiwan 1.4%

For APIs which are used without additional purification/reprocess

For APIs which required additional purification/reprocess

Reference: The Ministry of Health, Labour and Welfare’s Generic Drug Report conducted by Mitsubishi UFJ Research and Consulting Co., Ltd.

Key factors to choose overseas API suppliers for generic drugs manufacturing in Japan

0 20 40 60 80 100

1234

56

78

86.7%81.6%

67.7%64.6%

57.6%55.7%55.4%

42.4%

1. Meet Japan’s GMP standard2. Maintain a stable supply3. Competitive price4. Keep delivery date5. Quality control capability6. Management stability7. History with Japanese companies8. Social and political stability

Reference: The Ministry of Health, Labour and Welfare’s Generic Drug Report conducted by Mitsubishi UFJ Research and Consulting Co., Ltd.

Pharmaceutical Market Forecast(2017 - 2021)

Pharmaceutical market growth

Ageing PopulationJapan's ageing population will further drive demand for pharmaceutical products. By 2030, the pensionable population as a percentage of the total will grow to 31.2%, up from 25.8% in 2014.

Liberalisation of Over-The-Counter Medicines

The liberalisation of Over-The-Counter medicines and the allowance of sales of over-the-counter (OTC) drugs online serve to boost pharmaceutical sales. 99.8% of OTC drugs are now eligible for sale online (more than 11,000 drugs).

For more on market trends visit www.cphi.com/japan

Why Japan?

2017 2018 2019 2020 2021

105

100

95

US$bnin Sales

Reference: BMI

101.

853

103.

065 10

4.07

0

105.

147

102.

016

Research & DevelopmentJapan’s R&D remains at the forefront of the global pharmaceutical industry. This is a confluence of both the attractiveness of the country’s medicine market as well as the strength of local research institutions in the country. In biomedical R&D spending, Japan is the third largest in the world, accounting for approximately 10% of the total expenditure.

Exhibitor profile:Exhibitors at CPhI Japan are active in a range of business sectors, including:

Exhibitor profile of co-located shows:Exhibitors at ICSE, P-MEC, InnoPack and BioPh Japan are active in a range of business sectors, including:

ContractServices

Technology& Machinery

LaboratoryEquipment

Networking & learning at the show

Exhibitor Showcase Educate the industry about your products, services, new launches, innovations and news during a 30 minute presentation attended by visitors, press and fellow exhibitors. Create a buzz around your news at the show and benefit: • Maximise exposure before, during and after the event• Drive attendees to your stand• Generate new leads

Seminars Seminars on trending industry topics give valuable insight into the Japanese pharma industry. As the industry is undergoing change, be sure to attend and gain competitive advantage. Seminars included sessions by the Ministry of Health, Labour and Welfare, leading international and domestic pharmaceutical companies and prestigious universities.

Business Matchmaking Programme The “Business Matchmaking Programme” is a gateway for exhibitors to meet potential buyers. Exhibitors can find visitor enquiries on products or services they are looking for. You can contact the visitors whom you are interested in by making appointments. All exhibitors are welcome to participate FREE of charge!

CPhI Online Enhance online exposure of your company and products on CPhI Online. Stay connected with buyers before and after the show. With 42,000+ unique visitors per month, CPhI Online is a pharma sourcing directory that allows you to:• Generate leads• Increase brand awareness• Stay updated on pharma industry news and trends

Visitors’ top 3 job positions

41%

An event that is full of potential to expand existing business, explore new markets, learn the latest trends in the industry and to learn about the business culture.

Ashish TrivediDishman Pharmaceuticals and Chemicals Limited

“ “Packaging,

Drug delivery

Biopharmaceuticals

Non-Management Chugai, Otsuka, Nichi-Iko, Eisai, Otsuka

Ingredients Finished Formulation

%38Management Shionogi, Mitsubishi Pharma. Teijin,Taisho, Pfizer Japan

%

19CEO/Chairman/Vice President/Director Takeda, Astellas, Daiichi Sankyo, Mochida, Kyowa Hakko

gotocphi.com/jp19 For more information contact: salesoperations@ubm.com